Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Anti-Helicobacter Pylori IgM ELISA Kit

Das Human Anti-Helicobacter Pylori IgM ELISA Kit (ABIN997008) ist ein Colorimetric ELISA Kit zur Detektion von Human Anti-Helicobacter Pylori IgM.
Produktnummer ABIN997008
496,57 €
Zzgl. Versandkosten 20,00 € und MwSt
96 tests
Lieferung nach: Deutschland
Lieferung in 8 bis 12 Werktagen

Kurzübersicht für Anti-Helicobacter Pylori IgM ELISA Kit (ABIN997008)

Target

Anti-Helicobacter Pylori IgM

Reaktivität

  • 4
  • 1
Human

Nachweismethode

Colorimetric

Methodentyp

Competition ELISA

Applikation

ELISA

Proben

Serum
  • Verwendungszweck

    The ELISA, Helicobacter pylori IgM is intended for use in evaluating the serologic status to H. pylori infection in patients with gastrointestinal symptoms.

    Analytische Methode

    Qualitative

    Spezifität

    98%

    Sensitivität

    98%
  • Probenmenge

    5 μL

    Testdauer

    1 - 2 h

    Plattentyp

    Pre-coated

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Lagerung

    4 °C

    Haltbarkeit

    12-18 months
  • Target

    Anti-Helicobacter Pylori IgM

    Substanzklasse

    Antibody

    Hintergrund

    Helicobacter pylori is a spiral bacterium cultured from human gastric mucosa by Marshall in 1982. Studies have indicated that the presence of H. pylori is associated with a variety of gastrointestinal diseases including gastritis, duodenal and gastric ulcer, non-ulcer dyspepsia, gastric adenocarcinoma and lymphoma. The organism is present in 95-98% of patients with duodenal ulcer and 60-90% of patients with gastric ulcers. The studies have also demonstrated that removal of the organism by antimicrobial therapy is correlated with the resolution of symptoms and cure of diseases. Patients who present with clinical symptoms relating to the gastrointestinal tract can be diagnosed for H. pylori infection by two methods: 1) invasive techniques include biopsy followed by culture or histologic examination of biopsy specimen or direct detection of urease activity. 2) non-invasive techniques include urea breath tests and serological methods. All of the testing performed on biopsy samples are subject to errors related to sampling and interference of contaminated bacteria.
Sie sind hier:
Chat with us!